Dr Mark A Miller, in Chevy Chase, MD - Medicare Internal Medicine

Dr Mark A Miller, is a medicare enrolled "Internal Medicine" physician in Chevy Chase, Maryland. His current practice location is 4411 Leland St, Chevy Chase, Maryland. You can reach out to his office (for appointments etc.) via phone at (301) 496-0815.

Dr Mark A Miller is licensed to practice in Georgia (license number 035477) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1033349782.

Contact Information

	Dr Mark A Miller,
	4411 Leland St, Chevy Chase, MD 20815-6013
	(301) 496-0815
	Not Available

Physician's Profile

Full Name	Dr Mark A Miller
Gender	Male
Speciality	Internal Medicine
Location	4411 Leland St, Chevy Chase, Maryland
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1033349782
Provider Enumeration Date: 07/15/2009
Last Update Date: 07/15/2009

Medicare PECOS Information:

PECOS PAC ID: 4688860950
Enrollment ID: I20101129000642

Medical Identifiers

Medical identifiers for Dr Mark A Miller such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033349782	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	035477 (Georgia)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mark A Miller allows following entities to bill medicare on his behalf.

Entity Name	Yukon-kuskokwim Health Corporation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1447477815 PECOS PAC ID: 5193718765 Enrollment ID: O20040407001515

News Archive

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.

Finland commits 1.85M as initial funding for development of European biomedical research infrastructures

Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M- is to support preparation and pilot studies in 2010.

AP/Google.com examines efforts to address drug-resistant tuberculosis in China, other countries

The AP/Google.com on Monday examined efforts to prevent and control the spread of drug-resistant tuberculosis in China and other countries.

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark A Miller is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark A Miller, 4411 Leland St, Chevy Chase, MD 20815-6013 Ph: () -	Dr Mark A Miller, 4411 Leland St, Chevy Chase, MD 20815-6013 Ph: (301) 496-0815

News Archive

BioLineRx announces financial results for Q1 2014, provides operational update

Finland commits 1.85M as initial funding for development of European biomedical research infrastructures

AP/Google.com examines efforts to address drug-resistant tuberculosis in China, other countries

The AP/Google.com on Monday examined efforts to prevent and control the spread of drug-resistant tuberculosis in China and other countries.

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

Internal Medicine Doctors in Chevy Chase, MD

Dr. Rachel Kaiser, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5454 Wisconsin Ave, Suite 600, Chevy Chase, MD 20815 Phone: 301-942-7600
Dr. Allen A. Nimetz, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave, Suite 700, Chevy Chase, MD 20815 Phone: 301-656-5050 Fax: 301-654-4237
Dr. Ankit B Shah, M.D., M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8401 Connecticut Ave Ste 104, Chevy Chase, MD 20815 Phone: 240-892-7070 Fax: 240-248-0606
Dr. Steve A Burka, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 5530 Wisconsin Ave, #914, Chevy Chase, MD 20815 Phone: 301-654-3803 Fax: 301-654-3808
Dr. Sara Goldkind, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5630 Wisconsin Ave Apt 807, Chevy Chase, MD 20815 Phone: 240-353-0866
Dr. Robert J Marshall, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave Ste 700, Chevy Chase, MD 20815 Phone: 301-656-5050 Fax: 301-654-4237

Dr Mark A Miller, - Medicare Internal Medicine in Chevy Chase, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

BioLineRx announces financial results for Q1 2014, provides operational update

Finland commits 1.85M as initial funding for development of European biomedical research infrastructures

AP/Google.com examines efforts to address drug-resistant tuberculosis in China, other countries

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

BioLineRx announces financial results for Q1 2014, provides operational update

Finland commits 1.85M as initial funding for development of European biomedical research infrastructures

AP/Google.com examines efforts to address drug-resistant tuberculosis in China, other countries

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

Internal Medicine Doctors in Chevy Chase, MD